EGFR and squamous cell carcinoma: Notably, a shorter overall survival (OS) has been evidenced in patients of early or advanced CC with mutant KRAS and PIK3CA genes [66,71,74], as well in patients with squamous cell carcinomas and EGFR amplification [75].